CR9804A - VOLUME INCREASE AGENTS - Google Patents
VOLUME INCREASE AGENTSInfo
- Publication number
- CR9804A CR9804A CR9804A CR9804A CR9804A CR 9804 A CR9804 A CR 9804A CR 9804 A CR9804 A CR 9804A CR 9804 A CR9804 A CR 9804A CR 9804 A CR9804 A CR 9804A
- Authority
- CR
- Costa Rica
- Prior art keywords
- cellulose
- ethyl
- hydroxy
- weight
- present
- Prior art date
Links
- 229920002678 cellulose Polymers 0.000 abstract 3
- 239000001913 cellulose Substances 0.000 abstract 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 abstract 1
- 229920000896 Ethulose Polymers 0.000 abstract 1
- 239000001856 Ethyl cellulose Substances 0.000 abstract 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- 239000004067 bulking agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 abstract 1
- 239000001761 ethyl methyl cellulose Substances 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 abstract 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
Abstract
La presente composicion es capaz de formar una pelicula de particulas e incluye: (a) menos de un 99.65% por peso de al menos una particula; (b) al menos un agente de aumento de volumen escogido del grupo compuesto por: (i) celulosa escogida del grupo compuesto por etil hidroxi etil celulosa, hidroxi etil celulosa, hidroxi propil celulosa, hidroxi etil metil celulosa, hidroxi propil metil celulosa, metil celulosa, etil celulosa y etil metil celulosa y presente en una proporcion mayor al 0.35% por peso y (ii) componente no celulosico o celulosa distinta a la celulosa mencionada en el punto anterior (i) presente en una proporcion de al menos 0.05% por peso y opcionalmente (c) al menos un agente de esparcido. La composicion puede ser utilizada para formar peliculas para uso agricola.The present composition is capable of forming a particle film and includes: (a) less than 99.65% by weight of at least one particle; (b) at least one bulking agent chosen from the group consisting of: (i) cellulose chosen from the group consisting of ethyl hydroxy ethyl cellulose, hydroxy ethyl cellulose, hydroxy propyl cellulose, hydroxy ethyl methyl cellulose, hydroxy propyl methyl cellulose, methyl cellulose, ethyl cellulose and ethyl methyl cellulose and present in a proportion greater than 0.35% by weight and (ii) non-cellulosic or cellulose component other than cellulose mentioned in the previous point (i) present in a proportion of at least 0.05% per weight and optionally (c) at least one spreading agent. The composition can be used to form films for agricultural use.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59586205P | 2005-08-11 | 2005-08-11 | |
| US11/463,883 US20070037711A1 (en) | 2005-08-11 | 2006-08-10 | Film Forming Spreading Agents |
| US11/464,023 US7781375B2 (en) | 2005-08-11 | 2006-08-11 | Volumizing agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9804A true CR9804A (en) | 2008-07-01 |
Family
ID=44839417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9804A CR9804A (en) | 2005-08-11 | 2008-03-07 | VOLUME INCREASE AGENTS |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR9804A (en) |
-
2008
- 2008-03-07 CR CR9804A patent/CR9804A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR9803A (en) | SPREADING AGENTS FILM TRAINERS | |
| BR0112725A (en) | Antimicotic Nail Polish Composition | |
| AR068369A1 (en) | N4 XINAFOATE SALT - [(2,2-DIFLUOR-4H-BENZO [1,4] OXAZIN-3-ON) -6-IL] -5-FLUOR-N2- [3- (METHYLAMINOCARBONYLMETHYLENE) -FENYL] 2 , 4-PYRIMIDINDIAMINE " | |
| CL2007003730A1 (en) | Nanoemulsion comprising a) aqueous component and b) a carrier with i) 0.1-15% of a lipophilic component, ii) a surfactant and iii) a c3-c5 alcohol; composition optionally comprising it with an active agent; process for preparing the nanoemulsion and the composition; kit; and use to diagnose dermal and proliferative diseases, and treat viral, dermal and proliferative diseases. | |
| BR112012010112A2 (en) | surgical stapler for application through a small application port and a method of using the stapler to attach a tissue fold | |
| AR051322A1 (en) | AMITRAZ COMPOSITIONS | |
| ES2570856T3 (en) | Ophthalmic compositions containing a synergistic combination of two polymers | |
| EA200971081A1 (en) | PURINUM DERIVATIVES AND THEIR APPLICATION AS A TALL-SIMILAR RECEPTOR MODULATORS 7 | |
| CL2009001025A1 (en) | Lozenge composition comprising: a) a standard granule with at least: an alkaline buffering agent, a dissolution modifier and a filler, b) a defined extragranular nicotine active ingredient and at least one alkaline buffering agent; preparation procedure; Useful to eliminate or reduce tobacco use. | |
| AR070025A1 (en) | USE OF DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF COCLEAR TINNITUS AND PHARMACEUTICAL COMPOSITION | |
| AR077125A1 (en) | PHARMACEUTICAL COMBINATIONS USEFUL TO TREAT HCV | |
| MX2020005942A (en) | THIN ORAL FILM WITH HIGH LOAD OF ACTIVE AGENT. | |
| BRPI0805634A2 (en) | aqueous suspension concentrate (sc) composition, method for preparing a suspension concentrate, culture protection composition, method for protecting crops on site, use of composition and method for preventing particle agglomeration in a suspension concentrate | |
| CL2011000558A1 (en) | Crystalline forms of a compound derived from 2-thiazolyl-4-quinolinyl-oxy; Sodium salt of the compound, pharmaceutical composition comprising sodium salt, useful for treating hepatitis C virus infection. | |
| EP2305698A3 (en) | Macrocyclic inhibitors of Hepatitis C virus replication | |
| AR084932A1 (en) | OPHTHALMIC COMPOSITION INCLUDING AN ANDROGEN AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN EYE DISEASE RESULTING FROM AN ANDROGENIC DEFICIENCY | |
| AR076127A1 (en) | FORMULATION | |
| AR070356A1 (en) | PRODUCT FOR ORAL CARE AND METHODS OF USE OF THE SAME | |
| PE20100265A1 (en) | NEW PHARMACEUTICAL COMPOSITIONS INCLUDING LEVETIRACETAM AND PROCESS FOR ITS PREPARATION | |
| AR077139A1 (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT VCH | |
| GT200600307A (en) | DOSAGE METHODS OF ORAL DELAYED ORAL DISPOSAL OF OR-DEMETILVENLAFAXIN SUCCINATE | |
| WO2007022022A3 (en) | Volumizing agents | |
| BR0309057A (en) | Low dosage liquid formulations in entecavir and use | |
| BRPI0513944A (en) | substantially pure form of a quinazoline compound, use of a quinazoline compound and composition | |
| CO2021007612A2 (en) | Solid formulation of herbicidal composition and method of preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |